| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 外用药(元) | - | 26,701.23 | 22,623.35 | 56,657.31 | 40,898.38 |
| 西药(元) | - | 7,825,897.74 | 2,807,142.77 | 4,399,782.33 | 2,164,451.69 |
| 中成药内服(元) | 183,607.96 | 15,044,562.14 | 8,495,714.49 | 18,524,154.06 | 9,386,677.74 |
| 注射注液(元) | 4,224,497.98 | 22,059,073.20 | 14,299,359.77 | 25,329,867.93 | 11,910,939.89 |
| 房屋租赁收入(元) | - | 948,616.61 | - | 906,630.25 | - |
| 营业成本(元) | |||||
| 外用药(元) | - | 27,965.12 | 22,907.85 | 57,174.70 | 41,259.81 |
| 西药(元) | - | 7,893,929.46 | 2,818,812.54 | 4,419,477.28 | 2,180,596.68 |
| 中成药内服(元) | -26,745.89 | 11,692,624.88 | 5,353,716.42 | 12,507,834.18 | 6,267,627.92 |
| 注射注液(元) | 3,634,332.19 | 22,853,639.47 | 14,845,837.25 | 24,885,488.67 | 11,123,753.16 |
| 房屋租赁收入(元) | - | 516,414.83 | - | 497,161.66 | - |
| 毛利(元) | |||||
| 外用药(元) | - | -1,263.89 | -284.50 | -517.39 | -361.43 |
| 西药(元) | - | -68,031.72 | -11,669.77 | -19,694.95 | -16,144.99 |
| 中成药内服(元) | 210,353.85 | 3,351,937.26 | 3,141,998.07 | 6,016,319.88 | 3,119,049.82 |
| 注射注液(元) | 590,165.79 | -794,566.27 | -546,477.48 | 444,379.26 | 787,186.73 |
| 房屋租赁收入(元) | - | 432,201.78 | - | 409,468.59 | - |
| 毛利率(%) | |||||
| 外用药(%) | - | -4.73 | -1.26 | -0.91 | -0.88 |
| 西药(%) | - | -0.87 | -0.42 | -0.45 | -0.75 |
| 中成药内服(%) | 114.57 | 22.28 | 36.98 | 32.48 | 33.23 |
| 注射注液(%) | 13.97 | -3.60 | -3.82 | 1.75 | 6.61 |
| 房屋租赁收入(%) | - | 45.56 | - | 45.16 | - |
| 收入构成(%) | |||||
| 外用药(%) | - | 0.06 | 0.09 | 0.12 | 0.17 |
| 西药(%) | - | 17.05 | 10.95 | 8.94 | 9.21 |
| 中成药内服(%) | 4.17 | 32.77 | 33.15 | 37.64 | 39.94 |
| 注射注液(%) | 95.83 | 48.05 | 55.80 | 51.47 | 50.68 |
| 房屋租赁收入(%) | - | 2.07 | - | 1.84 | - |
| 毛利构成(%) | |||||
| 外用药(%) | - | -0.04 | -0.01 | -0.01 | -0.01 |
| 西药(%) | - | -2.33 | -0.45 | -0.29 | -0.42 |
| 中成药内服(%) | 26.28 | 114.78 | 121.61 | 87.83 | 80.19 |
| 注射注液(%) | 73.72 | -27.21 | -21.15 | 6.49 | 20.24 |
| 房屋租赁收入(%) | - | 14.80 | - | 5.98 | - |